Certolizumab pegol in the treatment of Crohn's disease: evidence from the PRECiSE clinical trial program

    Research output: Contribution to journalReview article

    Original languageEnglish
    Pages (from-to)459-465
    JournalCLINICAL INVESTIGATION
    Volume1
    Issue number3
    DOIs
    Publication statusPublished - 2011

    Cite this